Gilead Sciences Inc (GILD)

Jun 1, 2025, 8:03 AM EDT - 2 hours ago

Gilead's CAR-T cell therapy shows promise in deadly brain cancer

Jun 1, 2025, 8:00 AM EDT - 2 hours ago

Kite Presents New Real-World Data Supporting Use of Potentially Curative Yescarta® in Outpatient Care Setting for Patients with Relapsed/Refractory Large B-Cell Lymphoma at ASCO 2025

May 31, 2025, 8:30 AM EDT - 1 day ago

Potentially Earn 12%-15% Income: Monthly Options Series (June 2025)

AMAT APH AVGO BK BMI CTAS GL

May 31, 2025, 8:13 AM EDT - 1 day ago

Gilead's Trodelvy, with Keytruda, cuts breast cancer risk by 35% in trial

MRK

May 31, 2025, 8:00 AM EDT - 1 day ago

Trodelvy® Plus Keytruda® Reduces Risk of Disease Progression or Death by 35% Versus Keytruda and Chemotherapy in First-Line PD-L1+ Metastatic Triple-Negative Breast Cancer

May 30, 2025, 6:06 AM EDT - 2 days ago

Focus: Gilead commits to HIV prevention rollout for low-income countries despite funding uncertainty

May 29, 2025, 5:50 PM EDT - 2 days ago

Gilead Sciences, Inc. (GILD) Bernstein 41st Annual Strategic Decisions Conference (Transcript)

May 28, 2025, 12:22 PM EDT - 3 days ago

Jefferies' Michael Yee: Drug discovery could be one of the biggest beneficiaries of generative AI

AMGN BIIB DHR IBB ILMN NVS SDGR

May 26, 2025, 10:32 AM EDT - 5 days ago

Gilead Sciences' Best Days May Be Ahead - Here's Why

May 23, 2025, 8:30 AM EDT - 9 days ago

ASCENT-03: Trodelvy® Demonstrates Highly Statistically Significant & Clinically Meaningful Improvement in Progression Free Survival in Patients With First-line Metastatic Triple-Negative Breast Cancer Who Are Not Candidates for Checkpoint Inhibitors

May 22, 2025, 6:27 PM EDT - 9 days ago

Final Trade: WMT, GILD, DECK, ROST

WMT DECK ROST

May 21, 2025, 3:28 PM EDT - 10 days ago

Gilead Sciences, Inc. (GILD) RBC Capital Markets Global Healthcare Conference (Transcript)

May 15, 2025, 4:15 PM EDT - 16 days ago

Gilead and Kite Announce Presentation of Transformative Data in 1L Metastatic Triple-Negative Breast Cancer, Updated Results in Multiple Myeloma and Early Data From Novel Investigational CAR T-Cell Therapy Targeting Brain Cancer at 2025 ASCO and EHA

May 13, 2025, 7:32 PM EDT - 18 days ago

Gilead Sciences, Inc. (GILD) BofA Securities Health Care Conference Transcript

May 12, 2025, 12:36 PM EDT - 19 days ago

Dr. Scott Gottlieb: What to expect from President Trump's executive order to lower drug prices

ABBV AMGN AZN GSK JNJ LLY MRK

May 12, 2025, 12:30 PM EDT - 19 days ago

Trump Declares War On Pharma Drug Pricing, But The Stocks Aren't Tanking - Yet

ABBV AMGN BIIB BMY JNJ LLY MRK

May 8, 2025, 7:23 PM EDT - 23 days ago

Pressure is still on the pharma sector, says Mizuho's Jared Holz

ABBV AMGN BMY JNJ LLY MRK NVO

May 7, 2025, 2:52 PM EDT - 24 days ago

Gilead announces $11 billion in new investments in US

May 7, 2025, 2:30 AM EDT - 25 days ago

Final Data From the Phase 3 MYR301 Study Demonstrated Longer Treatment With Bulevirtide Was Associated With Sustaining Undetectability After Stopping Treatment

May 7, 2025, 2:15 AM EDT - 25 days ago

Gilead's Livdelzi® (Seladelpar) Demonstrated Consistent Efficacy and Safety Regardless of Prior Treatment History in New Data Presented at EASL 2025

Apr 29, 2025, 4:05 PM EDT - 4 weeks ago

Gilead Sciences to Present at Upcoming Investor Conferences

Apr 29, 2025, 1:51 PM EDT - 4 weeks ago

Gilead Sciences reaches $202 million settlement with US over kickbacks to doctors

Apr 29, 2025, 1:45 PM EDT - 4 weeks ago

Gilead Sciences agrees to pay $202 million to settle claims of kickbacks to doctors for HIV drug prescriptions

Apr 29, 2025, 8:30 AM EDT - 4 weeks ago

Gilead to Present Latest Advancements Across Primary Biliary Cholangitis and Viral Hepatitis

Apr 27, 2025, 7:00 AM EDT - 5 weeks ago

Wall Street's New Tariff Safe Haven: High-Tax Biotech Stocks

Apr 25, 2025, 6:06 PM EDT - 5 weeks ago

We're in a pharma stock pickers market, says Kessef's Len Yaffe

ABBV BMY JNJ LLY MRK PFE REGN

Apr 25, 2025, 10:35 AM EDT - 5 weeks ago

Gilead Sciences Q1 Earnings Review: HIV Division Masks Underperformance

Apr 25, 2025, 10:30 AM EDT - 5 weeks ago

AAPL Doubling India iPhone Production, TMUS Sells, GILD Healthcare Headwinds

AAPL TMUS

Apr 25, 2025, 8:27 AM EDT - 5 weeks ago

Skechers Posts Weak Revenue, Joins Intel, Gilead Sciences And Other Big Stocks Moving Lower In Friday's Pre-Market Session

INTC SKX

Apr 24, 2025, 8:02 PM EDT - 5 weeks ago

Gilead Sciences, Inc. (GILD) Q1 2025 Earnings Call Transcript

Apr 24, 2025, 4:09 PM EDT - 5 weeks ago

Gilead reports quarterly profit, revenue flat as cancer sales slow

Apr 24, 2025, 4:02 PM EDT - 5 weeks ago

Gilead Sciences Announces First Quarter 2025 Financial Results

Apr 24, 2025, 1:10 PM EDT - 5 weeks ago

Stocks on the Move: Merck, Gilead Sciences, P&G, PG&E Corp, Adobe and the URNM

ADBE MRK PCG PG URNM

Apr 21, 2025, 8:38 AM EDT - 5 weeks ago

Gilead says Trodelvy-Keytruda combo effective for aggressive breast cancer type

Apr 21, 2025, 8:30 AM EDT - 5 weeks ago

Trodelvy® Plus Keytruda® Demonstrates a Statistically Significant and Clinically Meaningful Improvement in Progression Free Survival in Patients With Previously Untreated PD-L1+ Metastatic Triple-Negative Breast Cancer

Apr 10, 2025, 4:05 PM EDT - 7 weeks ago

Gilead Sciences to Release First Quarter 2025 Financial Results on Thursday, April 24, 2025

Apr 9, 2025, 6:32 PM EDT - 7 weeks ago

BMO's Siegerman talks the impact of tariffs on pharmaceutical stocks

ABBV AMGN AZN BMY GSK JNJ LLY

Apr 4, 2025, 2:01 AM EDT - 2 months ago

Top 3 Nasdaq 100 stocks rising as it moves into a correction

EXC TMUS

Apr 2, 2025, 1:52 PM EDT - 2 months ago

Final Trades: Gilead Sciences, Amazon, Alphabet and KLA Corp.

AMZN GOOG GOOGL KLAC

Apr 1, 2025, 2:01 PM EDT - 2 months ago

Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks

ABBV AMGN BMY LLY MRK MRNA PFE

Mar 30, 2025, 8:00 AM EDT - 2 months ago

Earn A Potentially 12%-15% Income: Monthly Options Series (April 2025)

AMAT APH BK BMY CTAS EOG EQH

Mar 27, 2025, 10:22 AM EDT - 2 months ago

Trump Weighs Tariffs on Ireland's Pharma Industry. How to Play the Sector.

ABBV AMGN BIIB BMY IHE JNJ LLY

Mar 23, 2025, 12:36 PM EDT - 2 months ago

Gilead: Expansion Of Livdelzi For PBC Continues With European Marketing Approval

Mar 19, 2025, 9:22 AM EDT - 2 months ago

Gilead Stock Falls on Report Trump Administration Wants to Cut HIV-Prevention Funding

Mar 14, 2025, 1:51 PM EDT - 2 months ago

Calls of the Day: Shake Shack, Starbucks, 3M, Gilead Sciences, Eli Lilly

LLY SBUX SHAK MMM

Mar 12, 2025, 8:30 AM EDT - 2 months ago

Gilead Presents New HIV Treatment and Cure Research Data at CROI 2025, Including an Investigational Long-Acting, Twice-Yearly Therapy Option

Mar 11, 2025, 2:14 PM EDT - 2 months ago

Gilead Sciences, Inc. (GILD) Leerink Partners Global Healthcare Conference - (Transcript)

Mar 11, 2025, 1:40 PM EDT - 2 months ago

Stocks beating the stock market's recent Trump slump have this in common

ABBV AMGN BAX CVS PM SMCI TPL

Mar 11, 2025, 1:37 PM EDT - 2 months ago

First Clinical Data for Gilead's Investigational Once-Yearly Lenacapavir for HIV Prevention Presented at CROI 2025 and Published in The Lancet

Mar 5, 2025, 1:31 PM EST - 3 months ago

5 Big Biopharmaceutical Stocks That Are Finding Favor

ABBV AMGN JNJ LLY